Muscle loss linked to worse outcomes in lung disease patients
NCT ID NCT07178197
First seen Oct 31, 2025 · Last updated May 18, 2026 · Updated 29 times
Summary
This study looked at how muscle loss (sarcopenia) impacts quality of life and disease progression in 60 people with idiopathic pulmonary fibrosis (IPF). Researchers measured muscle strength, walking speed, and lung function, and used questionnaires to assess quality of life. The goal was to better understand the role of muscle health in IPF, but no treatment or intervention was tested.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mersin University Faculty of Medicine
Mersin, Mersin, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.